跳至主要内容
临床试验/NCT00164801
NCT00164801终止不适用

Is Visceral Hyperalgesia the Culprit of Noncardiac Chest Pain in Chinese? Part 2: Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP Patients

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2004年11月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
60
试验地点
1
主要终点
Esophageal sensory and pain thresholds

研究概览

简要总结

The effect of baclofen (GABAB agonist), diltiazem (muscle relaxant) and placebo will be compared in a double-blinded randomized study for the treatment of NCCP. Cerebral cortical, brainstem and spinal evoked potentials before and after treatment will be evaluated. Results of this study will shed lights on pathogenesis and treatment of NCCP in Chinese.We hypothesize that Baclofen alleviates visceral hyperalgesia in NCCP patients by suppressing afferent sensory pathway.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive patients with monthly angina-like chest pain and negative coronary angiogram or scintigraphy
  • Age between 18-70
  • Gastroesophageal reflux disease
  • Psychiatric illness
  • Cerebrovascular accident
  • Active peptic ulceration
  • Heart failure or cardiac bradyarrhythmia
  • Pregnancy or lactating female
  • Previous hypersensitivity to muscle relaxant

排除标准

  • 未提供

结局指标

主要结局

Esophageal sensory and pain thresholds

次要结局

  • Symptom severity of chest pain at the end of treatment
  • Evoked potential responses

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验